Vaccine maker BioNTech to use mRNA tech to target malaria

Refining surgical treatment of long-gap esophageal atresia in children
26 July 2021
Brain’s ‘memory center’ needed to recognize image sequences but not single sights
26 July 2021

Vaccine maker BioNTech to use mRNA tech to target malaria

Pharmaceutical company BioNTech said Monday that it wants to use the mRNA technology behind its coronavirus vaccine to target malaria.

Comments are closed.